Seer (SEER) Return on Capital Employed (2021 - 2026)
Seer (SEER) posted quarterly Return on Capital Employed of 27.21% for Q1 2026, up 61.0% year-over-year from 16.9% in Q1 2025, and little changed quarter-over-quarter from 27.21% in Q4 2025.
Seer (SEER) Return on Capital Employed (2021 - 2026) Analysis & Trends
Seer's Return on Capital Employed history runs 6 years deep, the most recent figure standing at 27.21% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 61.0% year-over-year to 27.21%; the TTM figure through Mar 2026 stood at 27.21% (up 61.0% YoY), while the FY2025 annual figure was 24.71%, up 122.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 27.21%, roughly flat from 27.21% in the prior quarter.
- The five-year high for Return on Capital Employed was 15.09% in Q1 2022, with the low at 27.98% in Q3 2025.
- The 5-year median for Return on Capital Employed is 24.31% (2024), against an average of 23.83%.
- The sharpest annual moves came in 2022 and 2025: Return on Capital Employed slumped 663 bps in 2022, then soared 62 bps in 2025.
- Seer's Return on Capital Employed stood at 20.19% in 2022, then slipped by 20 bps to 24.21% in 2023, then decreased by 15 bps to 27.83% in 2024, then rose by 2 bps to 27.21% in 2025, then slipped by 0 bps to 27.21% in 2026.
- Business Quant data shows SEER's Return on Capital Employed at 27.21% in Q1 2026, 27.21% in Q4 2025, and 27.98% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.76% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.74% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -55.45% |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.20% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 7.88% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 26.09% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -50.93% |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn | -27.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -27.98% |
| Mar 31, 2026 | -27.21% |
| Dec 31, 2025 | -27.21% |
| Sep 30, 2025 | -27.98% |
| Jun 30, 2025 | -27.57% |
| Mar 31, 2025 | -27.82% |
| Dec 31, 2024 | -27.83% |
| Sep 30, 2024 | -25.97% |
| Jun 30, 2024 | -25.26% |
| Mar 31, 2024 | -24.31% |
| Dec 31, 2023 | -24.21% |
| Sep 30, 2023 | -24.10% |
| Jun 30, 2023 | -23.36% |
| Mar 31, 2023 | -21.53% |
| Dec 31, 2022 | -20.19% |
| Sep 30, 2022 | -18.63% |
| Jun 30, 2022 | -16.88% |
| Mar 31, 2022 | -15.09% |
| Dec 31, 2021 | -13.74% |
| Sep 30, 2021 | -12.36% |